JNJ · Market closed
$268.52
-0.31% today·exchange $268.52
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
What Is AbbVie No Longer Telling You?
Trefis · 14h ago
What Is The Best Case For Pfizer Stock?
Trefis · 14h ago
Surgical Devices Market Size to Worth USD 27.14 Billion by 2030, at a CAGR of 14.7% – MarketsandMarkets™
GlobeNewswire · 16h ago
New model-based analysis further supports the potential of TECVAYLI® (teclistamab-cqyv) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma
PR Newswire · 17h ago
4 Elite Dividend Stocks Yielding Up to 6.14% With Diversified Pipelines That Protect Your Payout
24/7 Wall St. · 18h ago
Johnson & Johnson: What the Street’s Reaction to OTTAVA Actually Reveals About the Stock
TIKR · 18h ago
Headlines from Yahoo Finance. Not investment advice.